Color-Coded Rx Packaging Could Reduce Errors; Method Requires Study
Executive Summary
Color-coded drug packaging and labeling could help reduce medication errors in certain circumstances, but the method requires testing prior to adoption, participants at a March 7 FDA public hearing said
You may also be interested in...
Container Labels Expose Two Sides Of Color: Attention Getter, Lure To Medication Errors
FDA draft guidance lays out how sponsors can design drug container labels and carton labeling to avoid drug use mistakes by making the most important information accessible to health care providers and patients.
FDA Drug Name Guidance Is “Up In The Air,” Agency Tells DIA
FDA may not proceed with a planned guidance for industry on pre-marketing risk assessment of drug names, labeling and packaging, Medical Errors & Technical Support Division Deputy Director Carol Holquist said at the Drug Information Association annual meeting in Washington, D.C. June 16
Bristol Addresses Serzone/Seroquel Mix-Ups With Patient Information Leaflet
Bristol-Myers Squibb will distribute Serzone patient information leaflets with each prescription of the anti-depressant, to address medication mix-ups with AstraZeneca's anti-psychotic Seroquel